Shree Ganesh Biotech India Ltd Q1FY22 PAT at Rs. 68.22 lakhs

Shree Ganesh Biotech (India) Limited has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.15.56 crores during the period ended June 30, 2021 as compared to Rs.9.25 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.0.6822 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.0302 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.0.34 for the period ended June 30, 2021 as compared to Rs.0.02 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 15.56 crs	₹ 9.25 crs	68.22%
Net Profit	₹ 0.6822 crs	₹ 0.0302 crs	2158.94%
EPS	₹ 0.34	₹ 0.02	1600%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.15.56 crores during the period ended June 30, 2021 as compared to Rs.0.1135 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.0.6822 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.(0.0442) crores for the period ended June 30, 2020.

The company has reported EPS of Rs.0.34 for the period ended June 30, 2021 as compared to Rs.(0.02) for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 15.56 crs	₹ 0.1135 crs	13609.25%
Net Profit	₹ 0.6822 crs	₹ (0.0442) crs	1643.44%
EPS	₹ 0.34	₹ (0.02)	1800%

Shares of Shree Ganesh Biotech (India) Limited was last trading in BSE at Rs. 128.3 as compared to the previous close of Rs. 127.5. The total number of shares traded during the day was 18758 in over 47 trades.

The stock hit an intraday high of Rs. 129.95 and intraday low of 128.25. The net turnover during the day was Rs. 2410277.

Source : Equity Bulls

Keywords